Pharmaceutical

Pfizer settles Biohaven kickback claims case for $59.7m

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.

Jan 28, 2025 - 06:00
Pfizer settles Biohaven kickback claims case for $59.7m
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
Read the original article

Tags:

Previous Article

GSK and University of Oxford partner for cancer vaccine research

Next Article

MSD wins FDA priority review for Welireg in rare endocrine cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

How did hiring in the pharma industry perform in Q3 2023?

Oct 19, 2023

In N.C., Mandy Cohen built bridges to GOP. Can she find consensus as new CDC director?

In N.C., Mandy Cohen built bridges to GOP. Can she find...

Jul 14, 2023

Mind-altering ketamine becomes latest pain treatment, despite little research or regulation

Mind-altering ketamine becomes latest pain treatment, d...

Nov 7, 2023